Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease.

Alzheimers Res Ther · 2017 · PMC5316146 · PMID 28212683

Europe PMC DOI

hedged sentence

0.0700

closest p · 1.4× alpha

0.0700

boldest claim

The sentences

marginally nonsignificantp = 0.07so close (0.05 < p ≤ 0.1)

3b ) and marginally nonsignificant with the use of lovastatin (mean scores of 22.4 ± 9.7 SD, p = 0.07)—both of these are lipophilic statins predicted to have high blood–brain barrier penetration [ 55 ].

also in 448 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.